Due to the subclinical nature of heart involvement and a poor prognosis if treatment is delayed, we underline the importance of cardiac abnormalities screening in anti-MDA5 Ab+ DM/CADM patients at the time of diagnosis and during follow-up. Here, IFIH1 is linked to clinically amyopathic dermatomyositis.